Sandoz
Sandoz, a division of Novartis, is a global leader in the pharmaceutical industry, specialising in generic and biosimilar medicines. Headquartered in Holzkirchen, Germany, Sandoz operates extensively across Europe, North America, and emerging markets, providing high-quality, affordable healthcare solutions. Founded in 1886, the company has achieved significant milestones, including the launch of the first biosimilar in Europe. Sandoz is renowned for its extensive portfolio of generic pharmaceuticals, biosimilars, and over-the-counter products, which are distinguished by their rigorous quality standards and commitment to innovation. With a strong market position, Sandoz has been recognised for its contributions to increasing patient access to essential medications, making it a trusted name in the healthcare sector.
DitchCarbon Score
How does Sandoz's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Instruments industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sandoz's score of 40 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sandoz's reported carbon emissions
In 2023, Sandoz reported total carbon emissions of approximately 2.28 million tonnes CO2e, comprising 82.85 million tonnes from Scope 1 and 143.83 million tonnes from Scope 2 emissions. Notably, Scope 3 emissions accounted for about 2.05 million tonnes CO2e, with significant contributions from purchased goods and services (1.48 million tonnes) and upstream transportation and distribution (181.94 million tonnes). Sandoz has committed to near-term emissions reduction targets, although specific numerical targets have not been disclosed. The company is actively working towards reducing its carbon footprint within the pharmaceuticals, biotechnology, and life sciences sector. As of now, Sandoz has not committed to a net-zero target. In terms of emissions intensity, Sandoz reported a GHG emissions intensity of approximately 0.0227 tonnes CO2e per million USD in revenue for 2023, indicating a focus on improving efficiency alongside revenue growth. The company continues to prioritise sustainability initiatives as part of its operational strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 75,620,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 158,430,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sandoz is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
